Skip to main content

ADAS and Autonomous Driving Component Market

 The ADAS and autonomous driving component market is driven by the increasing technological developments and advancements in ADAS systems, rising developments in connected infrastructure and intelligent transportation system, demand for ADAS features in commercial vehicles, and growing concerns and measures over road safety. However, reliability issues, rising cyber threats in autonomous vehicles, high cost associated with LiDARs, and lack of government rules and regulations in developing regions, are limiting the market growth.

The global market for ADAS and autonomous driving component registered a market value of $23.93 billion in 2019 and is projected to grow at CAGR of 12.21% during 2020-2030.Several factors such as the increasing technological developments and advancements in ADAS systems, rising development in connected infrastructure and intelligent transportation system, and growing concerns and measures over road safety, drive the growth of this emerging technology.

The global ADAS and autonomous driving component market research provides a detailed perspective on the different types of products, their applications, value and volume estimation, among others. The principal purpose of this market analysis is to examine the ADAS and autonomous driving component market in terms of factors driving the market, restraints, trends, and opportunities, among others.

The report further considers the market dynamics, supply chain analysis, and the detailed product contribution of the key players operating in the market. The global ADAS and autonomous driving component market report is a compilation of different segments, including market breakdown by product type, application, region, and country.

The ADAS and autonomous driving component market segmentation (on the basis of component type) is further categorized into camera, radar, LiDAR, ultrasonic sensor, and ECU.

The ADAS and autonomous driving component market on the basis of level of autonomy is segregated into Level 1, Level 2, Level 3, Level 4, and Level 5.

The ADAS and autonomous driving component market on the basis of vehicle type is segregated into passenger vehicles, light commercial vehicles, heavy trucks, and heavy buses.

The ADAS and autonomous driving component market segmentation by region is segregated under seven major regions, namely, North America, Europe, China, Asia-Pacific and Japan, Middle East and Africa, South America, and the U.K.

Competitive Landscape

The global ADAS and autonomous driving component market competitive landscape consist of different strategies undertaken by key players across the industry to gain traction and market share presence. Some strategies adopted by the service providers are new product launches, business expansions, mergers, partnerships, and collaborations. Among all these strategies adopted, business expansion is the popular choice of the strategy implemented in the ADAS and autonomous driving component market. Some of the most prominent ecosystem players are Continental AG, Robert Bosch GmbH, Autoliv, Denso Corporation, Aptiv Plc, Texas Instruments, Analog Devices Inc.., Intel Corporation, LeddarTech Inc., Magna International Inc., Quanergy Systems Inc., Velodyne LiDAR, Inc., ZF Friedrichshafen AG, and Valeo.

Request a Sample - https://bisresearch.com/requestsample?id=1084&type=download

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...
Post a Comment
Read more

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...
Post a Comment
Read more